Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 2
2014 4
2015 7
2016 9
2017 16
2018 6
2019 9
2020 10
2021 5
2022 4
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Autoinflammatory disease, systemic, with vasculitis"
Page 1
Effects of rituximab therapy on B cell differentiation and depletion.
Bergantini L, d'Alessandro M, Cameli P, Vietri L, Vagaggini C, Perrone A, Sestini P, Frediani B, Bargagli E. Bergantini L, et al. Clin Rheumatol. 2020 May;39(5):1415-1421. doi: 10.1007/s10067-020-04996-7. Epub 2020 Feb 22. Clin Rheumatol. 2020. PMID: 32088800 Review.
It is largely used to treat B cell malignancies and has become standard in the management of B cell-mediated diseases such as rheumatoid arthritis and granulomatosis with polyangitis. ...Furthermore, in responder patients, indirect depletion of CD19(+/-)CD27(++)CD38(++) pr …
It is largely used to treat B cell malignancies and has become standard in the management of B cell-mediated diseases such as rheumat …
Pediatric Scleritis: An Update.
Tarsia M, Gaggiano C, Gessaroli E, Grosso S, Tosi GM, Frediani B, Cantarini L, Fabiani C. Tarsia M, et al. Ocul Immunol Inflamm. 2023 Jan;31(1):175-184. doi: 10.1080/09273948.2021.2023582. Epub 2022 Feb 28. Ocul Immunol Inflamm. 2023. PMID: 35226583
Although less frequently than in the adult population, scleral inflammation can be associated with systemic disorders, which should be promptly recognized and treated to avoid both ocular and systemic complications. Hence, a multidisciplinary diagnostic work-up shou …
Although less frequently than in the adult population, scleral inflammation can be associated with systemic disorders, which should b …
Management of Small Vessel Vasculitides.
Lopalco G, Rigante D, Venerito V, Emmi G, Anelli MG, Lapadula G, Iannone F, Cantarini L. Lopalco G, et al. Curr Rheumatol Rep. 2016 Jun;18(6):36. doi: 10.1007/s11926-016-0580-1. Curr Rheumatol Rep. 2016. PMID: 27118389 Review.
Inflammation mediated by cells of the immune system and necrosis are the most striking features observed at the histologic level in patients with vasculitides, clinical entities classified according to pathologic findings involving different organs, to etiology, or …
Inflammation mediated by cells of the immune system and necrosis are the most striking features observed at the histologic level in p …
Clinical features and long-term outcomes of patients with systemic polyarteritis nodosa diagnosed since 2005: Data from 196 patients.
Rohmer J, Nguyen Y, Trefond L, Agard C, Allain JS, Berezne A, Charles P, Cohen P, Gondran G, Groh M, Huscenot T, Lacout C, Lazaro E, London J, Maurier F, Mekinian A, Mesbah R, Nubourgh I, Perard L, Puéchal X, Pugnet G, Puyade M, Queyrel V, Roux A, Rouzaud D, Durel CA, Guillevin L, Terrier B; French Vasculitis Study Group (FVSG). Rohmer J, et al. J Autoimmun. 2023 Sep;139:103093. doi: 10.1016/j.jaut.2023.103093. Epub 2023 Aug 1. J Autoimmun. 2023. PMID: 37536165
Recent data regarding causes, characteristics, and prognosis of systemic PAN in the modern era are lacking. METHODS: This retrospective study included patients with systemic PAN referred to the French Vasculitis Study Group between 2005 and 2019. ...Secondary …
Recent data regarding causes, characteristics, and prognosis of systemic PAN in the modern era are lacking. METHODS: This retrospecti …
Sex-specific analysis in Behcet's disease reveals higher genetic risk in male patients.
Jo YG, Ortiz-Fernández L, Coit P, Yilmaz V, Yentür SP, Alibaz-Oner F, Aksu K, Erken E, Düzgün N, Keser G, Cefle A, Yazici A, Ergen A, Alpsoy E, Salvarani C, Kısacık B, Kötter I, Henes J, Çınar M, Schaefer A, Nohutcu RM, Takeuchi F, Harihara S, Kaburaki T, Messedi M, Song YW, Kaşifoğlu T, Martin J, González Escribano MF, Saruhan-Direskeneli G, Direskeneli H, Sawalha AH. Jo YG, et al. J Autoimmun. 2022 Oct;132:102882. doi: 10.1016/j.jaut.2022.102882. Epub 2022 Aug 18. J Autoimmun. 2022. PMID: 35987173 Free PMC article.
Meta-analysis of the effect in rs2848712 across six populations confirmed these results. Genetic risk score for Behcet's disease was significantly higher in male compared to female patients from Turkey. Higher genetic risk for Behcet's disease was observed …
Meta-analysis of the effect in rs2848712 across six populations confirmed these results. Genetic risk score for Behcet's disease …
Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.
Fonollosa A, Pelegrín L, García-Morillo S, Buján-Rivas S, Distefano L, Robles-Maruenda A, Fernández-Martín J, González-García A, Garcia-Aparicio Á, Ortego-Centeno N, Llorenç V, Sainz de la Maza M, Pinedo C, Sopeña B, Cocho L, Carreño E, Blanco R, Antón J, Pérez-Quintana M, Marques-Soares JR, Artaraz J, Ruiz-Arruza I, Soto-Peleteiro A, Gómez-Caverzaschi V, Araújo O, Espinosa G, Adan A, Fabiani C, Cantarini L, Hernández-Rodríguez J; Spanish Society of Ocular Inflammation (SEIOC) and the AutoInflammatory Diseases Alliance (AIDA) Network. Fonollosa A, et al. Clin Exp Rheumatol. 2023 Oct;41(10):2105-2114. doi: 10.55563/clinexprheumatol/ukegcc. Epub 2023 Sep 28. Clin Exp Rheumatol. 2023. PMID: 37812477 Free article.
OBJECTIVES: Ophthalmologic involvement in monogenic autoinflammatory diseases has been explored mainly in paediatric patients. The aim of this study is to characterise ophthalmologic manifestations, therapeutic management and visual outcomes in a Spanish (UVESAI) co …
OBJECTIVES: Ophthalmologic involvement in monogenic autoinflammatory diseases has been explored mainly in paediatric patients. …
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.
Triggianese P, Vitale A, Lopalco G, Mayrink Giardini HA, Ciccia F, Al-Maghlouth I, Ruscitti P, Sfikakis PP, Iannone F, de Brito Antonelli IP, Patrone M, Asfina KN, Di Cola I, Laskari K, Gaggiano C, Tufan A, Sfriso P, Dagna L, Giacomelli R, Hinojosa-Azaola A, Ragab G, Fotis L, Direskeneli H, Spedicato V, Dagostin MA, Iacono D, Ali HH, Cipriani P, Sota J, Kardas RC, Bindoli S, Campochiaro C, Navarini L, Gentileschi S, Martín-Nares E, Torres-Ruiz J, Saad MA, Kourtesi K, Alibaz-Oner F, Sevik G, Iagnocco A, Makowska J, Govoni M, Monti S, Maggio MC, La Torre F, Del Giudice E, Hernández-Rodríguez J, Bartoloni E, Emmi G, Chimenti MS, Maier A, Simonini G, Conti G, Olivieri AN, Tarsia M, De Paulis A, Lo Gullo A, Więsik-Szewczyk E, Viapiana O, Ogunjimi B, Tharwat S, Erten S, Nuzzolese R, Karamanakos A, Frassi M, Conforti A, Caggiano V, Marino A, Sebastiani GD, Gidaro A, Tombetti E, Carubbi F, Rubegni G, Cartocci A, Balistreri A, Fabiani C, Frediani B, Cantarini L. Triggianese P, et al. Intern Emerg Med. 2023 Nov;18(8):2231-2243. doi: 10.1007/s11739-023-03408-3. Epub 2023 Oct 12. Intern Emerg Med. 2023. PMID: 37828268 Free PMC article.
Patients with Still's disease classified according to internationally accepted criteria were enrolled in the AutoInflammatory Disease Alliance (AIDA) Still's Disease Registry. ...A total of 414 patients with Still's disease were included; 39 (9. …
Patients with Still's disease classified according to internationally accepted criteria were enrolled in the AutoInflammatory …
Risk of connective tissue disease, morphoea and systemic vasculitis in patients with hidradenitis suppurativa.
Schneeweiss MC, Merola JF, Schneeweiss S, Wyss R, Rosmarin D. Schneeweiss MC, et al. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):195-202. doi: 10.1111/jdv.16728. Epub 2020 Jul 31. J Eur Acad Dermatol Venereol. 2021. PMID: 32531094
Hazard ratios (HR) of developing CTD, morphoea and systemic vasculitis were computed after 1 : 1 propensity score (PS) matching. ...We did not observe an increased risk for systemic sclerosis HR = 0.90 (0.59-1.44), Sjogren's Syndrome HR = 0.91 ( …
Hazard ratios (HR) of developing CTD, morphoea and systemic vasculitis were computed after 1 : 1 propensity score (PS) …
An approach to the hospitalized patient with urticaria and fever.
Micheletti R, Rosenbach M. Micheletti R, et al. Dermatol Ther. 2011 Mar-Apr;24(2):187-95. doi: 10.1111/j.1529-8019.2011.01394.x. Dermatol Ther. 2011. PMID: 21410608 Review.
Most cases are readily treated symptomatically and have no systemic implications. However, a number of diseases and syndromes, including vasculitides, immunologic disorders, infectious diseases, hematologic diseases, and autoinflammatory …
Most cases are readily treated symptomatically and have no systemic implications. However, a number of diseases and syndromes, …
The administration of methotrexate in patients with Still's disease, "real-life" findings from AIDA Network Still Disease Registry.
Ruscitti P, Sota J, Vitale A, Lopalco G, Iannone F, Morrone M, Giardini HAM, D'Agostin MA, Antonelli IPB, Almaghlouth I, Asfina KN, Khalil N, Sfikakis PP, Laskari K, Tektonidou M, Ciccia F, Iacono D, Riccio F, Ragab G, Hussein MA, Govoni M, Ruffilli F, Direskeneli H, Alibaz-Oner F, Giacomelli R, Navarini L, Bartoloni E, Riccucci I, Martín-Nares E, Torres-Ruiz J, Cipriani P, Di Cola I, Hernández-Rodríguez J, Gómez-Caverzaschi V, Dagna L, Tomelleri A, Makowska J, Brzezinska O, Iagnocco A, Bellis E, Caggiano V, Gaggiano C, Tarsia M, Mormile I, Emmi G, Sfriso P, Monti S, Erten Ş, Del Giudice E, Lubrano R, Conti G, Olivieri AN, Lo Gullo A, Tharwat S, Karamanakos A, Gidaro A, Maggio MC, La Torre F, Cardinale F, Ogunjimi B, Maier A, Sebastiani GD, Opris-Belinski D, Frassi M, Viapiana O, Bizzi E, Carubbi F, Fotis L, Tufan A, Kardas RC, Więsik-Szewczyk E, Jahnz-Różyk K, Fabiani C, Frediani B, Balistreri A, Rigante D, Cantarini L. Ruscitti P, et al. Semin Arthritis Rheum. 2023 Oct;62:152244. doi: 10.1016/j.semarthrit.2023.152244. Epub 2023 Jul 21. Semin Arthritis Rheum. 2023. PMID: 37517110 Free article.
MTX was administered with GCs in 68.4% of patients, with other conventional synthetic DMARDs in 6.4%, and with biologic DMARDs in 25.1%. A significant reduction of the modified systemic score was observed, and 38.6% patients were codified as being in clinical …
MTX was administered with GCs in 68.4% of patients, with other conventional synthetic DMARDs in 6.4%, and with biologic DMARDs in 25.1%. A s …
75 results